Overview

[18F]FES PET/CT in PAH

Status:
Terminated

Trial end date:
2021-04-06

Target enrollment:

Participant gender:

Summary

In this study positron emission tomography (PET/CT) imaging will be used to evaluate evaluation of estrogen receptor heterogeneity and functionality in Pulmonary Arterial Hypertension (PAH) using the investigational radiotracer [18F]fluoroestradiol (FES).

Details

Lead Sponsor:

University of Pennsylvania